Longitudinal Changes of Insulin-like Growth Factors and Their Binding Proteins Throughout Normal Pregnancy
Overview
Authors
Affiliations
Background: Insulin-like growth factors (IGFs) are anabolic proteins that are essential regulators of cell division, differentiation and growth. We describe the longitudinal changes in IGF-I, IGF-II and the binding proteins IGFBP-1, -2 and -3 before and during normal pregnancy.
Method: Serum samples were taken before conception and then at 12, 24 and 36 weeks of gestation in 41 healthy women with uncomplicated pregnancies. We measured IGF-I using an automated chemiluminescent method, IGF-II and IGFBP-2 using in-house radioimmunoassays (RIAs), and IGFBP-1 and IGFBP-3 using commercial enzyme-linked immunosorbent assay (ELISA) and RIA kits, respectively. Because of the potential haemodilution effects during pregnancy, albumin was also measured in all samples.
Results: There was a significant fall in IGF-I during the first (36%) and second trimesters (21%) followed by an increase of 25% at 36 weeks. During pregnancy, the mean IGF-II concentrations fell by 12% at 12 weeks, 8% at 24 and 8% at 36 weeks compared with pre-conception values. When IGF-II results were adjusted for the haemodilution of pregnancy, its concentrations increased. During pregnancy, there was a rapid increase in mean IGFBP-1 levels by 17-fold (12 weeks), 24-fold (24 weeks) and 25-fold (36 weeks). IGFBP-2 concentrations fell after conception but started to increase towards term. This increase was more significant when adjusted for haemodilution. In contrast, IGFBP-3 concentrations increased significantly throughout pregnancy.
Conclusion: Our data on the physiological changes of IGFs and their binding proteins add further evidence of the vital roles of these hormones throughout normal pregnancy.
Pericuesta E, Gutierrez-Arroyo J, Sanchez-Calabuig M, Gutierrez-Adan A Int J Mol Sci. 2021; 22(7).
PMID: 33915805 PMC: 8037520. DOI: 10.3390/ijms22073657.
Castillo-Castrejon M, Yang I, Davidson E, Borengasser S, Jambal P, Westcott J J Nutr. 2020; 151(3):556-569.
PMID: 33382407 PMC: 7948206. DOI: 10.1093/jn/nxaa354.
Mense K, Heidekorn-Dettmer J, Wirthgen E, Brockelmann Y, Bortfeldt R, Peter S Front Endocrinol (Lausanne). 2018; 9:310.
PMID: 29946296 PMC: 6006986. DOI: 10.3389/fendo.2018.00310.
Romero R, Erez O, Maymon E, Chaemsaithong P, Xu Z, Pacora P Am J Obstet Gynecol. 2017; 217(1):67.e1-67.e21.
PMID: 28263753 PMC: 5813489. DOI: 10.1016/j.ajog.2017.02.037.
Schock H, Fortner R, Surcel H, Grankvist K, Pukkala E, Lehtinen M Int J Cancer. 2014; 137(2):439-47.
PMID: 25516257 PMC: 4428944. DOI: 10.1002/ijc.29387.